YCM
PTCT icon

Yousif Capital Management’s PTC Therapeutics PTCT Stock Holding History

Yousif Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.84M Buy
22,524
+380
+2% +$27.4K 0.02% 726
2026
Q1 		$1.51M Sell
22,144
-84
-0.4% -$5.95K 0.02% 827
2025
Q4 		$1.62M Buy
+22,228
New +$1.62M 0.02% 820

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Yousif Capital Management's PTCT Position: Q2 2026 in Review

Yousif Capital Management increased its PTC Therapeutics (PTCT) stake by 1.7% in Q2 2026, buying an estimated $27.4K and bringing the position to 22,524 shares worth $1.84M. The position accounts for 0.02% of the portfolio, ranked #726.

Yousif Capital Management first reported a position in PTCT in Q4 2025 and has held it in 3 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Yousif Capital Management held 22,524 shares of PTC Therapeutics worth $1.84M as of Q2 2026.
  • Yousif Capital Management bought 380 PTC Therapeutics shares in Q2 2026, an estimated $27.4K.
  • PTC Therapeutics made up 0.02% of Yousif Capital Management's portfolio in Q2 2026, its #726 holding.
  • Yousif Capital Management first reported a position in PTC Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.